Recent 8-K filings for USNA

• May 20, 2026, 4:24 PM ET other materiality 0.02 neutral item 5.07

  USANA shareholders re-elect all eight directors, ratify KPMG, approve advisory comp at annual meeting

  Each of eight director nominees received over 13.6M votes for; no nominee had material withheld count.

• May 5, 2026, 7:59 PM ET earnings materiality 0.65 negative item 2.02item 7.01item 9.01 ◈ Earnings Releases

  USANA Q1 2026 EPS down 16% YoY to $0.41; reaffirms FY guidance

  Net sales $250M flat YoY; net earnings $7.5M (-20%); diluted EPS $0.41 vs $0.49.

• February 18, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  USANA Q4 net loss $1.8M; core customers down 15%; FY2026 guidance flat to 8% growth

  Q4 net loss $1.8M vs profit $4.5M YoY; adjusted diluted EPS $0.60 (down 6% from $0.64).

• February 11, 2026, 6:59 PM ET leadership materiality 0.70 neutral item 5.02item 9.01

  USANA sets CEO Guest compensation at $850K base, $1.7M RSU; Brown gets $1.5M severance

  Jim Brown transitions to strategic advisor through Dec 31, 2026; receives $825K salary, eligible for 2025 bonus, benefits.

• January 12, 2026, 6:59 PM ET other material materiality 0.65 neutral item 2.02item 7.01item 9.01

  USANA prelim FY2025 sales ~$925M (beat guidance); FY2026 guidance $925M-$1B

  Preliminary FY2025 net sales of ~$925M, above prior guidance of ~$920M.

• January 8, 2026, 6:59 PM ET leadership materiality 0.70 positive item 5.02item 7.01item 9.01

  USANA CEO Jim Brown steps down; Kevin Guest returns as CEO effective immediately

  Jim Brown stepped down as CEO and President after 19 years; will remain in advisory role.

• October 22, 2025, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 7.01item 9.01

  USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20

  Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.

• October 9, 2025, 7:59 PM ET earnings materiality 0.85 negative item 2.02item 7.01item 9.01

  USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut

  Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.

• July 22, 2025, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 7.01item 9.01

  USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated

  Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).

• July 1, 2025, 7:59 PM ET debt materiality 0.55 neutral item 1.01item 2.03item 9.01 ◈ Debt Financings

  USANA enters $75M revolving credit facility with Bank of America, $200M accordion option

  New $75M revolver replaces prior agreement; includes $200M accordion feature subject to conditions.

• May 20, 2025, 7:59 PM ET other material materiality 0.65 neutral item 5.02item 5.07item 8.01

  USANA shareholders approve 2025 Equity Incentive Plan at annual meeting

  All eight director nominees elected, including Kevin G. Guest and Xia Ding.

• April 22, 2025, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 7.01item 9.01

  USANA Q1 net sales up 10% to $250M; EPS down 43% to $0.49; reiterates FY outlook

  Net sales $250M (+10% YoY); net earnings $9.4M (-43%); diluted EPS $0.49 vs $0.86.

• March 7, 2025, 6:59 PM ET M&A materiality 0.75 positive item 9.01

  USANA acquires controlling interest in Hiya Health Products; Hiya posts $80.9M revenue, $14.9M net income in 9M 2024

  USANA acquired controlling interest in Hiya on Dec 23, 2024; audited financials of Hiya now filed.

• February 25, 2025, 6:59 PM ET earnings materiality 0.80 negative item 2.02item 7.01item 9.01

  USANA Q4 net sales -3% to $214M; net earnings -73% to $4.5M; FY2025 guidance includes Hiya

  Q4 net sales $214M (-3% YoY); net earnings $4.5M (-73%); diluted EPS $0.23 (-74%).

• December 23, 2024, 6:59 PM ET M&A materiality 0.85 positive item 1.01item 2.01item 7.01item 9.01

  USANA acquires 78.8% stake in Hiya Health for $205M; Hiya had $103M sales, $22M adjusted EBITDA LTM

  Acquired 78.8% controlling stake in Hiya Health for $205M cash; closed Dec 23, 2024.

• October 22, 2024, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  USANA Q3 net sales $200M (-6% YoY); cuts FY2024 EPS guidance to $2.45

  Q3 diluted EPS $0.56 vs $0.59 YoY; net sales down 6% to $200M.

• July 23, 2024, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  USANA Q2 net sales $213M (-11% YoY), EPS $0.54 (-39%); cuts FY2024 guidance

  Diluted EPS $0.54 vs. $0.89 in Q2 2023; net sales $213M down 11% YoY to $238M.

• May 7, 2024, 7:59 PM ET other material materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×3

  USANA shareholders re-elect eight board members, ratify KPMG, approve say-on-pay at annual meeting

  All eight director nominees elected; vote totals ranged from 15.9M (Gilbert Fuller) to 16.86M (Kevin Guest) shares for.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.70 · Most common event earnings

3 positive 7 negative 8 neutral

source · USNA on sec.gov